Physician , at University at Buffalo, United States.
Dr. Rina Kansal is an accomplished physician-scientist and board-certified pathologist specializing in molecular oncology, hematopathology, and medical genetics. With a dynamic career that spans clinical diagnostics, academic leadership, and translational research, Dr. Kansal has consistently demonstrated excellence across multiple domains of pathology. Her journey reflects a rare blend of deep clinical expertise, rigorous academic training, and an enduring commitment to precision medicine. She has held leadership roles in top institutions and has been recognized nationally for her contributions to medical science and healthcare.
Professional Profile
Scopus
Orcid
Google Scholar
Education 🎓
Dr. Kansal began her medical journey at Maulana Azad Medical College, University of Delhi, graduating with an M.B.B.S. degree in 1986. She later earned multiple prestigious credentials, including Diplomate certifications from the American Board of Pathology in Anatomic & Clinical Pathology (1999), Hematopathology (2000), and Molecular Genetic Pathology (original certification 2014, updated in 2024). She also holds certifications in Medical Education Research (2022) and has passed international licensing exams including the USMLE, PLAB (UK), and MRCP Part 1 (UK). Her postgraduate training includes fellowships in Molecular Genetic Pathology at UCLA, Hematopathology at the University of Michigan, and Oncologic Pathology at Roswell Park Cancer Institute.
Experience 👩
Dr. Kansal most recently served as Associate Medical Director in Molecular Oncology and Genetics at the Blood Center of Wisconsin (Versiti), where she led clinical diagnostics and molecular testing strategies. She previously held academic appointments as Associate Professor of Pathology at Penn State University, and served as Staff Hematopathologist and Visiting Scientist at Cedars-Sinai Medical Center in Los Angeles. Earlier in her career, she directed Hematopathology and Flow Cytometry at the Medical College of Wisconsin. Throughout her positions, she has combined patient care, diagnostics, education, and research to deliver impactful medical solutions.
Research Interests 🔬
Dr. Kansal’s research lies at the intersection of molecular diagnostics, hematologic malignancies, and personalized medicine. Her work explores the application of advanced genetic tools for diagnosing blood cancers and solid tumors, bridging clinical practice with molecular innovation. She has pursued scholarly activities in flow cytometry, cytogenetics, and next-generation sequencing, contributing to evolving paradigms in molecular pathology. Through her experience at Cedars-Sinai, UCLA, and Penn State Hershey Medical Center, she has remained deeply engaged in translational research with a strong focus on precision medicine.
Awards 🏆
Dr. Kansal has received numerous accolades throughout her career. In 2024, she was honored as a Top Scholar in Precision Medicine by ScholarGPS and selected for the American Society of Hematology’s Advocacy Leadership Institute in Washington, D.C. She was named Top Doctor by regional magazines for Buffalo, NY (2021) and Hershey, PA (2019). She earned a Leadership Institute Certification from the American Society for Clinical Pathology in 2019, and previously received recognition from Labome for her AAAS membership. Her clinical excellence was also commemorated with a service award from the University of Michigan’s Hematopathology Department in 2001.
Top Noted Publications 📚
Title: Towards a one-time cure for Fabry disease: Lentivirus-mediated haematopoietic stem and progenitor cell gene therapy
Author: Rina R. Kansal
Citations: 0
Title: The CRISPR-Cas System and Clinical Applications of CRISPR-Based Gene Editing in Hematology with a Focus on Inherited Germline Predisposition to Hematologic Malignancies
Author: Rina R. Kansal
Citations: 3
Conclusion
Dr. Rina Kansal possesses outstanding credentials in molecular pathology and hematology, with leadership roles, prestigious fellowships, and recent recognitions. However, for a Best Researcher Award, especially on a national or international scale, her CV would benefit from:
A clear list of publications
Evidence of ongoing funded research
Demonstrated impact in the academic or research community